Trial Profile
Brain Imaging of Quetiapine Response in Anxious Depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Anxiety disorders; Major depressive disorder
- Focus Therapeutic Use
- 26 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Sep 2009 New trial record